Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
01/1999
01/06/1999CN1204364A Production of water stress or salt stress tolerant transgenic cereal plants
01/06/1999CN1203948A Promoter of human endoglin gene and its use
01/06/1999CN1203947A Promoter of cdc25B gene, its preparation and use
01/06/1999CN1203922A Humanized anti-human fas antibody
01/06/1999CN1203921A Membrane protein polypeptide having pre-B cell growth-supporting ability and gene thereof
01/06/1999CN1203920A Method for producing recombinant human interleukin-6
01/06/1999CN1203919A 3'-monophosphorylated oligonucleotides
01/06/1999CN1203791A Vital engineering, factor and factor inducing, expressing regulation area and construction
01/06/1999CN1041535C Nucleotide sequence encoding carbamoyl phosphate synthetase II
01/05/1999US5856466 Coupling 2'-o-alkylated guanosine 3'-o-phosphoramidite with a 5'-hydroxyl moiety on an oligonucleotide
01/05/1999US5856463 PSKH-1 ribozymes
01/05/1999US5856462 Oligonucleotides having modified CpG dinucleosides
01/05/1999US5856461 Antibody
01/05/1999US5856459 Oligonucleotides specific for hepatitis B virus
01/05/1999US5856458 Isolated nucleotide sequence
01/05/1999US5856457 To obtain dna encoding pf4a receptors, and to express them in host cells.
01/05/1999US5856456 Connecting polypeptides
01/05/1999US5856454 Isolated nucleic acids
01/05/1999US5856448 Materials involved in the control of the cardiovascular system, and in particular to activities mediated by thrombin and its cellular receptor.
01/05/1999US5856447 Vaccine against lyme disease
01/05/1999US5856443 Molecular cloning and expression of G-protein coupled receptors
01/05/1999US5856442 Relates to a procedure for obtaining immunomodulating soluble proteins.
01/05/1999US5856437 Genetic engineering
01/05/1999US5856435 Gene therapy; transferring nucleic acids
01/05/1999US5856302 Therapeutic uses of bactericidal/permeability-increasing protein dimer products
01/05/1999US5856301 Administering polypeptide
01/05/1999US5856297 Human C3b/C4b receptor (CR1)
01/05/1999US5856296 DNA encoding interleukin-4 receptors
01/05/1999US5856201 Methods of detection using a cellulose binding domain fusion product
01/05/1999US5856188 Hairpin ribozymes
01/05/1999US5856187 Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments
01/05/1999US5856185 Method for making reflection defective retroviral vectors for infecting human cells
01/05/1999US5856181 Cytopathic viruses for therapy and prophylaxis of neoplasia
01/05/1999US5856180 Immortalization of dendritic cells with V-MYC oncogene
01/05/1999US5856177 Promoters derived from the maize phosphoenolpyruvate carboxylase gene involved in C4 photosynthesis
01/05/1999US5856174 Integrated nucleic acid diagnostic device
01/05/1999US5856171 Cell death regulators
01/05/1999US5856170 Concerned with the development of an improved vaccine against pneumococcal infections.
01/05/1999US5856169 Isolated nucleic acid
01/05/1999US5856166 Endogenous to streptomyces cells degrades heterologous secreted from streptomyces host cell
01/05/1999US5856164 Dishwashing; cleaning compound
01/05/1999US5856163 Lipases from hyphozyma
01/05/1999US5856162 Receptor-type phosphotyrosine phosphatase-κ
01/05/1999US5856160 Polynucleotides; hybrid detector
01/05/1999US5856157 Δ9 14:0-ACP fatty acid desaturase and gene therefor
01/05/1999US5856155 Nucleic acid which encodes a polypeptide consisting of a core region of a .beta.-subunit of a shaker-like potassium ion channel
01/05/1999US5856154 Dna sequences
01/05/1999US5856153 Suicide genes and new associations of pyrimidine nucleobase and nucleoside analogs with new suicide genes for gene therapy of acquired diseases
01/05/1999US5856152 Transgenic supplying to cells
01/05/1999US5856151 Antifungal preparations containing osmotin
01/05/1999US5856148 Materials and methods for biosynthesis of serine and serine-related products
01/05/1999US5856146 Recombinant thermostable enzyme which releases trehalose from non-reducing saccharide
01/05/1999US5856145 Process for lysing mycobacteria
01/05/1999US5856144 Vector incorporates single nucleotide overhangs at one or both ends of a linearized dna segment.
01/05/1999US5856142 Periplasmic expression enables recombinant proteins which are, in principle, correctly folded to be obtained directly in a space protected from the environment.
01/05/1999US5856140 Human interleukin-2 response blocker
01/05/1999US5856139 Proline-rich acidic protein
01/05/1999US5856138 Human parathyroid hormone muteins and production thereof
01/05/1999US5856137 Nucleic acids encoding and recombinant production of the β subunit of lutenizing hormone
01/05/1999US5856136 Human stem cell antigens
01/05/1999US5856133 G-beta-gamma regulated phosphatidylinositol-3'kinase
01/05/1999US5856132 G-beta-gamma regulated phosphatidylinositol-3' kinase
01/05/1999US5856129 Hydridized detector
01/05/1999US5856127 Antimicrobial peptides
01/05/1999US5856126 Peptide having anti-thrombus activity and method of producing the same
01/05/1999US5856125 ETS2 repressor factor (ERF) genetic locus and its products
01/05/1999US5856124 DNA encoding high-affinity melatonin receptors
01/05/1999US5856123 Expression of polypeptides in yeast
01/05/1999US5856121 Nucleotide sequence
01/05/1999US5856116 The structure coordinates of the enzyme may be used to design novel classes of ice inhibitors.
01/05/1999US5856103 Method for selectively ranking sequences for antisense targeting
01/05/1999US5856102 Home/self-storage to improve DNA banking
01/05/1999US5856099 Hybridization; nucleoside oligomers
01/05/1999US5856098 Detection of this receptor variant in cells of obese individuals, and methods for treating obesity by targeting variant.
01/05/1999US5856093 Terminal nucleotides are detected and removed from polynucleotide
01/05/1999US5856091 Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2
01/05/1999US5856090 DNA-methylase linking reaction
01/05/1999US5856084 Recombinant dna molecules which code for polypeptides having specificity towards a hepatitis b viral antigen.
01/05/1999US5855911 Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
01/05/1999US5855910 Cationic phospholipids for transfection
01/05/1999US5855891 Ichimeric papillomavirus-like particles
01/05/1999US5855889 Polypeptide antibody
01/05/1999US5855886 Immunoassay method involving fewer, preferably only one, reaction steps than conventional immunoassay in a therapeutic application, two prodrugs may be released which only become active for treatment when both are present.
01/05/1999US5855883 Method of disinsertion of vitreous body from neural retina of the eye with Proteus vulgaris chondroitinases I and II
01/05/1999US5855881 Mammalian alcohol dehydrogenase and aldehyde dehydrogenase production in plants
01/05/1999US5855880 Avirulent microbes and uses therefor
01/05/1999US5855879 Hybrid gramnegative bacteria
01/05/1999CA2131415C Vector for liver-specific gene therapy
01/05/1999CA2078373C Peptides for the production of preparations for the diagnosis and therapy of systemic lupus
01/05/1999CA2067692C Method for lysing mycobacteria
01/05/1999CA1340301C Vaccines against animal parasitic nematodes
01/04/1999CA2237041A1 Process for producing microbial transglutaminase
01/03/1999CA2236462A1 Murc
01/02/1999CA2221861A1 Ynl075w/htxft19
01/01/1999CA2236459A1 Novel compounds
01/01/1999CA2236452A1 Gida1
01/01/1999CA2236441A1 Gida2
01/01/1999CA2236435A1 Gida2
01/01/1999CA2236425A1 Gida1
01/01/1999CA2235785A1 Serine/threonine protein kinase (h-sgk2)